Senators Ron Wyden and Jeff Merkley (both D-OR) have introduced the Cannabinoid Safety and Regulation Act, establishing a federal framework for hemp-derived cannabinoids like CBD. The bill comes as the industry faces upheaval from recent legislation that would recriminalize many hemp products starting next November.
Key Provisions:
The legislation sets default THC limits for states without their own caps: 5mg per serving and 50mg per container (10mg for beverages). The FDA would enforce safety standards and prevent marketing to minors.
Products would require sellers to register with FDA, restrict sales to those 21+, and meet federal labeling requirements. Synthetically derived cannabinoids would be banned. The bill defines total THC to include delta-8, delta-9, delta-10, THC-A, and HHC.
States retain authority to impose stricter rules or ban products entirely, but must allow interstate transport of hemp cannabinoids.
Funding:
- $125 million for cannabis use prevention (HHS)
- $200 million annually for five years (CDC) for data collection and prevention programs
- $40 million for impaired driving enforcement grants
- $30 million for impaired driving detection research
Both senators emphasized their approach as a “thoughtful and measured” alternative to outright prohibition, protecting consumers while supporting the industry and jobs.
We’ll keep you posted.